NCT07144176View on ClinicalTrials.gov

PK and Safety Comparison of DWJ1511 and DWC202501 in Healthy Volunteers

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Healthy Subjects
Interventions
DRUG

DWJ1511

Test drug: DWJ1511

DRUG

DWC202501

Comparator: DWC202501

Trial Locations (1)

08779

RECRUITING

H Plus Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY